Krakow, Poland

Charles-Henry Fabritius

This inventor holds 6 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Ryvu Therapeutics S.a., Felicitex Therapeutics, Inc., Nodthera Limited. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles-Henry Fabritius. Retrieved from https://idiyas.com/inventor/charles-henry-fabritius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.9

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Charles-Henry Fabritius

Introduction: Charles-Henry Fabritius, an accomplished inventor based in Cracow, Poland, is renowned for his impactful contributions to medical science through his innovative patents. With a total of four patents to his name, Fabritius has focused on developing compounds that play a crucial role in enhancing immune responses.

Latest Patents: Among Fabritius's latest patents are the inventions related to next-generation modulators of the stimulator of interferon genes (STING). These patents describe compounds of formula (I) and their salts, stereoisomers, tautomers, or N-oxides, which are essential for modulating STING. The compounds are further intended for use as medicaments and as part of pharmaceutical compositions, highlighting their potential therapeutic applications.

Career Highlights: Throughout his career, Fabritius has worked with prominent companies in the biotechnology sector, such as Ryvu Therapeutics S.A. and Nodthera Limited. His work in these companies showcases his dedication to advancing scientific research and the application of innovative solutions in the medical field.

Collaborations: In his journey as an inventor, Fabritius has collaborated with talented colleagues, including Magdalena Izabela Zawadzka and Maciej Krzysztof Rogacki. These collaborations have undoubtedly enriched his research and contributed to the success of his inventions.

Conclusion: Charles-Henry Fabritius stands out as a significant figure in modern scientific innovation. His latest patents focused on STING modulation illustrate the importance of his work in the medical community. As he continues to develop new solutions, Fabritius's contributions will likely lead to impactful advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…